Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points

Journal of the American College of Cardiology

Volumn 34, Issue 1, 1999, Pages 191-196

  Ommen, Steve R ^a   Nishimura, Rick A ^a   Squires, Ray W ^a   Schaff, Hartzell V ^a   Danielson, Gordon K ^a   Tajik, A Jamil ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE OXYGEN CONSUMPTION; HEART PACING; HEART VENTRICLE SEPTUM; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MUSCLE RESECTION; PRIORITY JOURNAL; TREADMILL EXERCISE; TREATMENT OUTCOME;

AGED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART SEPTUM; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; TREATMENT OUTCOME;

EID: 0033165555     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00173-4     Document Type: Article

References (32)

1. Diodati J.G., Schenke W.H., Waclawiw M.A., et al. Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy. Am J Cardiol. 69:1992;1617-1622.
2. McCully R.B., Nishimura R.A., Tajik A.J., et al. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 94:1996;467-471.
3. Mohr R., Schaff H.V., Puga F.J., Danielson G.K. Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age. Circulation. 80:1989;I191-I6.
4. Mohr R., Schaff H.V., Danielson G.K., et al. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years. J Thorac Cardiovasc Surg. 97:1989;666-674.
5. Morrow A.G., Reitz B.A., Epstein S.E., et al. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation. 52:1975;88-102.
6. Williams W.G., Wigle E.D., Rakowski H., et al. Results of surgery for hypertrophic obstructive cardiomyopathy. Circulation. 76:1987;V104-V8.
7. Fananapazir L., Epstein N., Curiel R., et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy . Circulation. 90:1994;2731-2742.
8. Fananapazir L., Cannon R.O., Tripodi D., Panza J.A. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation. 85:1992;2149-2161.
9. Nishimura R.A., Hayes D.L., Ilstrup D.M., et al. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol. 27:1996;431-432.
10. Nishimura R.A., Trusty J.M., Hayes D.L., et al. Dual-chamber pacing for hypertrophic cardiomyopathy a randomized, double-blind, crossover trial . J Am Coll Cardiol. 29:1997;435-441.
11. Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med. 336:1997;775-785.
12. Wigle E.D., Rakowski H., Kimball B.P., Williams W.G. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 92:1995;1680-1692.
13. Rakowski H., Sasson Z., Wigle E. Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 1:1988;31-47.
14. Sasson Z., Yock P., Hatle L., et al. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol. 11:1988;752-756.
15. Nishimura R., Tajik A., Reeder G., Seward J. Evaluation of hypertrophic cardiomyopathy by Doppler color flow imaging initial observations . Mayo Clin Proc. 61:1986;631-639.
16. Maron B. Hypertrophic cardiomyopathy. Curr Probl Cardiol. 18:1993;639-704.
17. Wigle E.D., Sasson Z., Henderson M.A., et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 28:1985;1-83.
18. Cannon R.O., McIntosh C.L., Schenke W.H., et al. Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. Circulation. 79:1989;766-775.
19. Cannon R.O. 3d, Dilsizian V., O'Gara P.T., et al. Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy. Circulation. 85:1992;1039-1045.
20. Cooper M.M., Tucker E., McIntosh C.L., et al. Effect of left ventricular septal myectomy on concurrent mitral regurgitation. Ann Thorac Surg. 48:1989;251-256.
21. Criley J.M., Siegel R.J. Has 'obstruction' hindered our understanding of hypertrophic cardiomyopathy? Circulation. 72:1985;1148-1154.
22. Criley J.M. Unobstructed thinking (and terminology) is called for in the understanding and management of hypertrophic cardiomyopathy. J Am Coll Cardiol. 29:1997;741-743.
23. Oakley C.M. Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy. Br Heart J. 74:1995;479-480.
24. Seiler C., Hess O.M., Schoenbeck M., et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy a retrospective study . J Am Coll Cardiol. 17:1991;634-642.
25. Schulte H.D., Bircks W.H., Loesse B., et al. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thor Cardiovasc Surg. 106:1993;709-717.
26. ten Berg J.M., Suttorp M.J., Knaepen P.J., et al. Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy [see comments]. Circulation. 90:1994;1781-1785.
27. Mohr R., Schaff H., Danielson G., et al. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy experience over 15 years . J Thorac Cardiovasc Surg. 97:1989;666-674.
28. Fananapazir L., McAreavey D. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. J Am Coll Cardiol. 31:1998;259-264.
29. Maron B.J., Nishimura R.A., McKenna W.J., et al. Assessment of dual-chamber pacing as a treatment of drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy a randomized, double-blind, crossover trial (M-PATHY) . Circulation. 98:1998;I506.
30. Tripodi D., Fananapazir L. Five year results of dual chamber (DDD) pacing for severe drug-refractory symptoms in obstructive hypertrophic cardiomyopathy. PACE Pacing Clin Electrophysiol. 20:1997;1102.
31. Seggewiss H., Gleichmann U., Faber L., et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy acute results and 3-month follow-up in 25 patients . J Am Coll Cardiol. 31:1998;252-258.
32. Lakkis N.M., Nagueh S.F., Kleiman N.S., et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 98:1998;1750-1755.